AU2002342968B2 - Fatty acid compounds, preparation and uses thereof - Google Patents

Fatty acid compounds, preparation and uses thereof Download PDF

Info

Publication number
AU2002342968B2
AU2002342968B2 AU2002342968A AU2002342968A AU2002342968B2 AU 2002342968 B2 AU2002342968 B2 AU 2002342968B2 AU 2002342968 A AU2002342968 A AU 2002342968A AU 2002342968 A AU2002342968 A AU 2002342968A AU 2002342968 B2 AU2002342968 B2 AU 2002342968B2
Authority
AU
Australia
Prior art keywords
group
atom
carbon atoms
saturated
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002342968A
Other languages
English (en)
Other versions
AU2002342968A1 (en
Inventor
Karine Caumont-Bertrand
Jamila Najib-Fruchart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfit SA
Original Assignee
Genfit SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit SA filed Critical Genfit SA
Publication of AU2002342968A1 publication Critical patent/AU2002342968A1/en
Application granted granted Critical
Publication of AU2002342968B2 publication Critical patent/AU2002342968B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
AU2002342968A 2001-08-09 2002-08-08 Fatty acid compounds, preparation and uses thereof Ceased AU2002342968B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0110645A FR2828487B1 (fr) 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations
FR0110645 2001-08-09
PCT/FR2002/002831 WO2003014073A1 (fr) 2001-08-09 2002-08-08 Composes derives d'acides gras preparation et utilisations

Publications (2)

Publication Number Publication Date
AU2002342968A1 AU2002342968A1 (en) 2003-06-19
AU2002342968B2 true AU2002342968B2 (en) 2008-05-15

Family

ID=8866413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342968A Ceased AU2002342968B2 (en) 2001-08-09 2002-08-08 Fatty acid compounds, preparation and uses thereof

Country Status (13)

Country Link
US (1) US7375135B2 (enExample)
EP (1) EP1673338B1 (enExample)
JP (1) JP2004537595A (enExample)
AT (1) ATE373638T1 (enExample)
AU (1) AU2002342968B2 (enExample)
CA (1) CA2456288A1 (enExample)
CY (1) CY1107806T1 (enExample)
DE (1) DE60222596T2 (enExample)
DK (1) DK1673338T3 (enExample)
ES (1) ES2292824T3 (enExample)
FR (1) FR2828487B1 (enExample)
PT (1) PT1673338E (enExample)
WO (1) WO2003014073A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
CN100351259C (zh) * 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
FR2850650B1 (fr) * 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
FR2850870B1 (fr) * 2003-02-12 2006-07-28 Genfit S A Utilisation therapeutique de glycerols acyles et de leurs analogues azotes et sulfures
FR2853834B1 (fr) * 2003-04-17 2008-08-15 Vincience Composition cosmetique ou pharmaceutique comprenant l'association d'au moins un diacyglycerol et d'au moins un alcool gras
FR2858216B1 (fr) * 2003-07-31 2008-04-04 Oreal Composition contenant un 2-thioacetamide, son utilisation pour stimuler la pousse des fibres keratiniques et/ou freiner leur chute
RU2261705C1 (ru) * 2004-01-29 2005-10-10 Медведев Илья Николаевич Способ лечения тромбоцитопатии при метаболическом синдроме
MX2007000816A (es) * 2004-07-19 2007-06-05 Thia Medica As Composicion que comprende material de proteina y compuestos que comprenden entidades de acido graso no oxidable.
RU2394598C2 (ru) * 2004-07-19 2010-07-20 Тиа Медика Ас Композиция, содержащая белковый материал и соединения, содержащие неокисляющиеся структурные элементы жирных кислот
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
DE102007051338A1 (de) * 2007-10-26 2009-04-30 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
EP2217224B1 (en) 2007-11-09 2019-05-08 Basf As Lipid compounds for use in cosmetic products, as food supplement or as a medicament
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
EA021177B1 (ru) 2009-05-08 2015-04-30 Пронова Биофарма Норге Ас Полиненасыщенные жирные кислоты для лечения заболеваний, связанных с сердечно-сосудистыми, метаболическими и воспалительными заболеваниями
EP2445494A4 (en) * 2009-06-24 2012-12-12 Univ Koebenhavn TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE
ES2618604T3 (es) 2010-11-05 2017-06-21 Pronova Biopharma Norge As Métodos de tratamiento usando compuestos lipídicos
KR102213143B1 (ko) 2013-02-28 2021-02-08 바스프 에이에스 지방질 화합물, 트리글리세리드 및 계면활성제를 포함하는 조성물 및 이를 이용하는 방법
CA2904898C (en) 2013-03-11 2019-10-15 Jan Remmereit Lipid compositions containing bioactive fatty acids
HK1220606A1 (zh) 2013-03-11 2017-05-12 Nobesita As 包含非可氧化脂肪酸的天然脂类
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
KR102644400B1 (ko) 2015-04-28 2024-03-06 바스프 에이에스 비알코올성 지방간염의 예방 및/또는 치료를 위한 구조적으로 강화된 함황 지방산의 용도
CN107709349B (zh) 2015-05-20 2022-01-28 阿比尔技术公司 植物提取物组合物和制备其的方法
US10266708B2 (en) 2015-09-16 2019-04-23 Apeel Technology, Inc. Precursor compounds for molecular coatings
FR3044556B1 (fr) 2015-12-08 2019-10-18 Pierre Fabre Dermo-Cosmetique Utilisation de diglyceride 1,3 dans une composition topique pour lutter contre la fragilisation de la barriere cutanee
CN112841185A (zh) 2015-12-10 2021-05-28 阿比尔技术公司 用于形成保护性涂层的植物提取物组合物
CN109068627B (zh) 2016-01-26 2022-03-18 阿比尔技术公司 用于制备和保存消毒产品的方法
EP3541192B1 (en) 2016-11-17 2025-06-25 Apeel Technology, Inc. Methods of preparing fatty acid esters from crosslinked polyesters
EP3661600A4 (en) 2017-10-23 2021-08-11 Epitracker, Inc. FATTY ACID ANALOGS AND ITS USE IN THE TREATMENT OF DISEASES RELATED TO METABOLISM SYNDROME
US11925614B2 (en) 2017-12-06 2024-03-12 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
CA3099561A1 (en) * 2018-05-16 2019-11-21 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to aging
JP2021525249A (ja) 2018-05-23 2021-09-24 エピトラッカー インコーポレイテッドＥｐｉｔｒａｃｋｅｒ， Ｉｎｃ． 加齢及び長期性の質に関連する状態の診断及び治療のための組成物及び方法
US12245605B2 (en) 2018-09-05 2025-03-11 Apeel Technology, Inc. Compounds and formulations for protective coatings
WO2020146263A1 (en) 2019-01-09 2020-07-16 Epitracker, Inc. Compositions and methods for diagnosis and treatment of neurodegenerative diseases
JP7404382B2 (ja) 2019-03-04 2023-12-25 エピトラッカー インコーポレイテッド 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
WO2021178553A1 (en) 2020-03-04 2021-09-10 Apeel Technology, Inc. Coated agricultural products and corresponding methods
WO2022094339A1 (en) 2020-10-30 2022-05-05 Apeel Technology, Inc. Compositions and methods of preparation thereof
WO2023039077A1 (en) 2021-09-08 2023-03-16 Apeel Technology, Inc. Compounds and formulations for protective coatings
WO2023080939A1 (en) 2021-11-03 2023-05-11 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity
US12133863B1 (en) * 2023-06-07 2024-11-05 King Saud University Green synthesis of silver nanoparticles encapsulated in a nanostructured lipid carrier

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010154A (en) * 1933-06-27 1935-08-06 Herbert S Kreighbaum Ether acid ester of polyhydric alcohols
DE2028240A1 (de) * 1969-06-11 1970-12-23 Mitsubishi Petrochemical Co, Ltd., Tokio; Shipro Kasei Kaisha Ltd., Osaka; (Japan) Gegen thermischen Abbau stabilisierte Polyolefinzusammensetzung
US4134770A (en) * 1976-09-22 1979-01-16 Mitsubishi Paper Mills, Ltd. Gelatin-containing photographic layer incorporated with hardener
EP0018342A1 (fr) * 1979-03-06 1980-10-29 Sanofi S.A. Nouveaux dérivés du glycerol, leurs procédés de préparation ainsi que les compositions pharmaceutiques les contenant
EP0447553A1 (en) * 1989-09-11 1991-09-25 Kao Corporation Bleaching composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5738616B2 (enExample) * 1974-06-19 1982-08-17
JPS5782573A (en) * 1980-11-05 1982-05-24 Matsumoto Yushi Seiyaku Kk Smoothening treatment agent for thermoplastic synthetic fiber
GB8813012D0 (en) * 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
NO952796D0 (no) 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
CA2301943C (en) 1997-08-29 2008-11-04 The Johns Hopkins University Antimicrobial compounds
JP2000169443A (ja) 1998-10-02 2000-06-20 Sankyo Co Ltd ジチオ―ル誘導体
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
CN100351259C (zh) * 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
FR2850650B1 (fr) 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850870B1 (fr) * 2003-02-12 2006-07-28 Genfit S A Utilisation therapeutique de glycerols acyles et de leurs analogues azotes et sulfures
FR2850969B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Aminopropanediols acyles et analogues et leurs utilisations therapeutiques
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010154A (en) * 1933-06-27 1935-08-06 Herbert S Kreighbaum Ether acid ester of polyhydric alcohols
DE2028240A1 (de) * 1969-06-11 1970-12-23 Mitsubishi Petrochemical Co, Ltd., Tokio; Shipro Kasei Kaisha Ltd., Osaka; (Japan) Gegen thermischen Abbau stabilisierte Polyolefinzusammensetzung
US4134770A (en) * 1976-09-22 1979-01-16 Mitsubishi Paper Mills, Ltd. Gelatin-containing photographic layer incorporated with hardener
EP0018342A1 (fr) * 1979-03-06 1980-10-29 Sanofi S.A. Nouveaux dérivés du glycerol, leurs procédés de préparation ainsi que les compositions pharmaceutiques les contenant
EP0447553A1 (en) * 1989-09-11 1991-09-25 Kao Corporation Bleaching composition

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts Registry Numbers 58888-36-1 and 58888-37-2 *
Chemical Abstracts Registry Numbers 83995-03-3 *
Chemistry and Physics of Lipids 112(1):59- *
Journal of Biological Chemistry 263(29):14832-8 *
Journal of the Chemical Society 51(13):165-9 *
Journal OrganicChemistry 58(7):1952-4 *
Liebigs Ann. Chem.1980 pp 858-62 *

Also Published As

Publication number Publication date
DE60222596D1 (de) 2007-10-31
FR2828487B1 (fr) 2005-05-27
EP1673338B1 (fr) 2007-09-19
DE60222596T2 (de) 2008-07-24
DK1673338T3 (da) 2008-01-14
US7375135B2 (en) 2008-05-20
PT1673338E (pt) 2007-12-12
FR2828487A1 (fr) 2003-02-14
EP1673338A1 (fr) 2006-06-28
CA2456288A1 (fr) 2003-02-20
ATE373638T1 (de) 2007-10-15
WO2003014073A1 (fr) 2003-02-20
CY1107806T1 (el) 2013-06-19
JP2004537595A (ja) 2004-12-16
ES2292824T3 (es) 2008-03-16
US20040192908A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
AU2002342968B2 (en) Fatty acid compounds, preparation and uses thereof
US11685735B2 (en) Pharmaceutical composition comprising berberine salts for the treatment of various diseases or disorders
US5093365A (en) Non-β-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals
CN102427809B (zh) 用于治疗代谢性疾病的抗炎剂和抗氧化剂轭合物
AU2016228304B2 (en) Isoprenyl compounds and methods thereof
US20020048798A1 (en) Novel antioxidants
ES2287529T3 (es) Composicion a base de derivados de 1,3-difenilprop-2-en-1-ona sustituidos, preparaciones y usos de la misma.
KR100394986B1 (ko) 비-베타-산화성지방산유사체를주성분으로하는치료용약제
KR20020072296A (ko) 특이 구조를 가진 일 군의 항암 화합물 및 그 제조방법
KR20050061400A (ko) 황-함유 인지질 유도체
WO2003084532A1 (en) Lipoic acid analogs useful as provitamins and antioxidants
CA2572796A1 (en) Lipid-amino acid conjugates and methods of use
US20080058412A1 (en) 1,3-Diphenylprop-2-En-1-One Derivative Compounds, Preparation Method Thereof and Uses of Same
US20060035977A1 (en) Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same f
FR2892414A1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
US20060252827A1 (en) Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof
WO2007048787A1 (fr) Derives d'amino-acides contenant un groupement disulfanyle comme inhibiteurs mixtes de la neprilysine et de l 'aminopeptidase n

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired